EUVIMEDEUVIMED entdecken
Crossref

Effectiveness and safety of oral vancomycin in non‐primary sclerosing cholangitis paediatric inflammatory bowel disease

Silvana Ancona iD, Laura Gianolio, Katherine Armstrong, Rosalind Rabone, Victoria Merrick, Paul Henderson, David C Wilson, Richard K Russell iD

Journal of Pediatric Gastroenterology and Nutrition · 2026

DOI: 10.1002/jpn3.70180 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pediatric Gastroenterology and Nutrition, 2026. Verfasst von Silvana Ancona und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatric Gastroenterology and Nutrition, Royal Hospital for Children and Young People, Edinburgh, UK. Hauptthemen laut MEDLINE: Vancomycin, Anti-Bacterial Agents, Cholangitis, Sclerosing, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: None.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Oral vancomycin (OV) has limited usage in paediatric inflammatory bowel disease (PIBD) with reported efficacy in primary sclerosing cholangitis (PSC‐PIBD), acute severe colitis as part of quadruple‐antibiotic regimen, and very early‐onset IBD. This study evaluates OV effectiveness and safety as a single‐agent in non‐PSC PIBD.

Methods

This single‐centre retrospective study included patients on OV for active disease or steroid/topical therapy dependency. Exclusion criteria were PSC diagnosis, Clostridioides difficile infection, induction treatment started

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

VancomycinAnti-Bacterial AgentsCholangitis, SclerosingInflammatory Bowel DiseasesHumansFemaleRetrospective StudiesMaleChildAdolescentAdministration, OralTreatment OutcomeColitis, Ulcerative

Stichwörter der Autor:innen

Crohn's diseaseantibioticsinflammatory bowel disease unclassifiedulcerative colitis

Substanzen

VancomycinAnti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Paediatric Gastroenterology and Nutrition, Royal Hospital for Children and Young People, Edinburgh, UK.
  • Department of Paediatrics, Vittore Buzzi Children's Hospital, University of Milan, Milan, Italy.
  • Child Life and Health, University of Edinburgh, Edinburgh, UK.

ORCID-Profile: Silvana Ancona, Richard K Russell

Förderung

  • None

Zitieren

APA

Ancona, S., Gianolio, L., Armstrong, K., Rabone, R., Merrick, V., Henderson, P., Wilson, D. C., & Russell, R. K. (2026). Effectiveness and safety of oral vancomycin in non‐primary sclerosing cholangitis paediatric inflammatory bowel disease. Journal of Pediatric Gastroenterology and Nutrition. https://doi.org/10.1002/jpn3.70180

Vancouver

Ancona S, Gianolio L, Armstrong K, Rabone R, Merrick V, Henderson P, et al. Effectiveness and safety of oral vancomycin in non‐primary sclerosing cholangitis paediatric inflammatory bowel disease. Journal of Pediatric Gastroenterology and Nutrition. 2026. doi:10.1002/jpn3.70180

BibTeX
@article{Ancona2026,
  author = {Ancona, Silvana and Gianolio, Laura and Armstrong, Katherine and Rabone, Rosalind and Merrick, Victoria and Henderson, Paul and Wilson, David C and Russell, Richard K},
  title = {Effectiveness and safety of oral vancomycin in non‐primary sclerosing cholangitis paediatric inflammatory bowel disease},
  journal = {Journal of Pediatric Gastroenterology and Nutrition},
  year = {2026},
  doi = {10.1002/jpn3.70180}
}
Kostenlos starten →